Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants

American Journal of Epidemiology

Volumn 164, Issue 4, 2006, Pages 342-348

  Volcik, Kelly A ^a   Barkley, Ruth Ann ^a   Hutchinson, Richard G ^b   Mosley, Thomas H ^b   Heiss, Gerardo ^c   Sharrett, A Richey ^d   Ballantyne, Christie M ^e   Boerwinkle, Eric ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoproteins E; Carotid arteries; Coronary disease; Lipoproteins, LDL cholesterol; Polymorphism, genetic

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AFRICAN AMERICAN; ALLELE; CARDIOVASCULAR DISEASE; POLYMORPHISM; RISK FACTOR;

ADULT; AFRICAN AMERICAN; ALLELE; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPID TRANSPORT; MAJOR CLINICAL STUDY; MALE; PREDICTION;

AFRICAN CONTINENTAL ANCESTRY GROUP; APOLIPOPROTEINS E; CAROTID ARTERIES; CHOLESTEROL, LDL; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; TUNICA INTIMA;

NORTH AMERICA; UNITED STATES;

EID: 33748074100     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj202     Document Type: Article

References (40)

1. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med 1991;91:3S-9S.
2. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993;71:9B-14B.
3. Manolio TA, Burke GL, O'Leary DH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 1999;19:356-65.
4. Giral P, Filitti V, Levenson J, et al. Relation of risk factors for cardiovascular disease to early atherosclerosis detected by ultrasonography in middle-aged normotensive hypercholesterolemic men. Atherosclerosis 1990;85:151-9.
5. Heiss G, Sharrett AR, Barnes R, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991;134:250-6.
6. Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994;139:1164-79.
7. Folsom AR, Eckfeldt J, Weitzman S. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 1994;25:66-73.
8. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid artery intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
9. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
10. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
11. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
12. Sing CF, Davignon J. Role of apolipoprotein E genetic polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268-85.
13. Ehnholm C, Lukka M, Kuusi T, et al. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-35.
14. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
15. Xhignesse M, Lussier-Cacan S, Sing CF, et al. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 1991;11:1100-10.
16. Kamboh MI, Aston CE, Ferrell RE, et al. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis 1993;98:201-11.
17. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984;65:237-41.
18. Wilson PW, Myers RH, Larson MG, et al. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA 1994;272:1666-71.
19. Terry JG, Howard G, Mercuri M, et al. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke 1996;27:1755-9.
20. Horejsi B, Spacil J, Ceska R, et al. The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness. Int Angiol 2000;19:331-6.
21. Ilveskoski E, Loimaala A, Mercuri MF, et al. Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men. Atherosclerosis 2000;153:147-53.
22. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004;141:137-47.
23. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702.
24. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and non-respondents in a multi-center community-based study vary by gender and ethnicity. J Clin Epidemiol 1996;49:1441-6.
25. White A, Folsom A, Chambless L, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial 2 years' experience. J Clin Epidemiol 1996;49:223-33.
26. Siedel J, Hagele EO, Ziegenhorn J, et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-85.
27. Friedwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
28. Warnick GR, Benderson JM, Albers JJ. Quantitation of highdensity lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation. (Abstract). Clin Chem 1982;28:1574.
29. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). The ARIC Study Group. J Neuroimaging 1991;1:68-73.
30. Stevens J, Tyroler HA, Cai J, et al. Body weight change and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1998;147:563-73.
31. Chambless LE, Zhong MM, Arnett D, et al. Variability in B-mode ultrasound measurements in the Atherosclerosis Risk in Communities (ARIC) Study. Ultrasound Med Biol 1996;22:545-54.
32. Djousse L, Myers RH, Province MA, et al. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: NHLBI Family Heart Study. Stroke 2002;33:1357-61.
33. Beilby JP, Hunt CCJ, Palmer LJ, et al. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Stroke 2003;34:869-74.
34. Fillenbaum GG, Burchett BM, Lee JH, et al. Mortality and apolipoprotein E in African-American and white elders: an attempted replication. Am J Med Genet A 2003;119:141-6.
35. Elosua R, Ordovas JM, Cupples LA, et al. Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J Lipid Res 2004;45:1868-75.
36. Slooter AJC, Bots ML, Havekes LM, et al. Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam Study. Stroke 2001;32:1947-52.
37. de Andrade M, Thandi I, Brown S, et al. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995;56:1379-90.
38. Moliterno DJ, Jokinen EV, Miserez AR, et al. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 1995;15:850-5.
39. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108-13.
40. Mahley RW, Rall SC Jr. Type III hyperlipoproteinemia (dys- betalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited disease. Vol II. New York, NY: McGraw-Hill, 1995:1953-80.